SecureKloud Tech
Q2 FY21 Earnings Call Analysis
IT - Services
fundraise: Yescapex: Yesrevenue: Category 3margin: Category 2orderbook: Yes
π°fundraise
Any current/future new fundraising through debt or equity?
- The board approved a capital raising plan of approximately Rs.150 Crores (around USD 20 million) for Blockedge Technologies Inc., a 100% subsidiary of SecureKloud, to be presented for shareholder approval at the AGM on September 30, 2021.
- The subsidiary fundraise is planned as equity investment (capital raising).
- Regarding Healthcare Triangleβs NASDAQ listing, the company is anticipating raising around USD 25 million, but the exact dilution or pricing is not yet determined as it awaits SEC clearance.
- SecureKloud aims to keep dilution low by raising around USD 25 million in funds but has capacity to raise more if needed.
- No specific mention of new debt fundraising was made in the call.
- Overall, current focus is on equity fundraising for growth initiatives particularly for Blockedge and Healthcare Triangle's listing.
ποΈcapex
Any current/future capex/capital investment/strategic investment?
- The board approved a capital raising plan of approximately Rs.150 Crores (USD 20 million) for Blockedge Technologies Inc., a 100% US-based subsidiary of SecureKloud.
- The approval was given on the day of the call (August 6, 2021), with shareholder approval planned for the AGM on September 30, 2021.
- The funds raised will be used to support sales and marketing efforts specific to the Blockedge platform.
- SecureKloud is continuing to invest in sales and marketing, including hiring new sales personnel to drive growth.
- Investments in product development and enhancements continue for platform-based services such as DRaaS, CloudEz, and DataEz.
- The company focuses on building a platform-as-a-service business model with recurring revenue streams.
πrevenue
Future growth expectations in sales/revenue/volumes?
- Revenue growth expected in the next two quarters as the company witnesses shift from one-time revenue to recurring revenue model.
- Addition of new sales force and investment in sales & marketing to speed up customer acquisition.
- Growth potential in Blockedge blockchain platform with dedicated sales team planned, aiming to increase revenue substantially.
- Expansion into new verticals such as pharma, automotive, insurance, land registry, and government sectors.
- Geographic expansion in Europe, Middle East, Japan, UK, India, US, and other markets.
- Multiyear contracts and recurring revenues from existing and new clients enhancing revenue visibility.
- Collaboration with consortiums in pharma and automotive to broaden customer base.
- Anticipated steady growth in recurring revenues, currently at 36.9%, led by Life Sciences and Healthcare sectors.
- Focus on platform-as-a-service business model for higher enterprise value.
πmargin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Revenue growth is expected in the next few quarters due to increased sales efforts and a healthy sales pipeline, especially with new client acquisitions and expansion in various geographies including Europe, Middle East, Japan, UK, and India.
- Transition from one-time revenue to recurring revenue models (SaaS/platform as a service) is anticipated to support sustainable growth and improve margins.
- Gross margins were impacted by higher low-margin revenue share, subcontracting costs, and salary revisions, but operational improvements like automation and productivity enhancements are planned to offset these.
- Investment in sales and marketing has been substantial; benefits of this will reflect in revenue growth and margins in coming quarters.
- Focus on platform-based services such as CloudEz, DataEz, and Blockedge, with potential in pharma, automotive, and government sectors, is expected to drive high-value enterprise growth.
- Profits should improve sequentially as revenue grows and operational efficiencies increase.
πorderbook
Current/ Expected Orderbook/ Pending Orders?
- SecureKloud has a strong order backlog in Life Sciences and Healthcare verticals.
- New logos acquired in the last two quarters, including seven new logos in the current quarter from India and the US.
- Expansion plans in Europe, Middle East, and Japan aimed at reducing dependency on large customers.
- Healthy sales pipeline with promising traction in new client opportunities.
- Top five to ten customers contribute the majority of revenue.
- Expect revenue uptick to start reflecting in the next couple of quarters.
- Multiyear agreements being discussed with customers in healthcare for implementation, support services, and Disaster Recovery as a Service (DRaaS).
- Some past customers have returned due to positive engagement and service quality.
